» Articles » PMID: 27708217

The Role of Surgical Intervention in Primary Colorectal Lymphoma: A SEER Population-based Analysis

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Oct 7
PMID 27708217
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary colorectal lymphoma (PCL) is a rare colorectal malignancy. The standard treatment and prognostic factors of PCL remain unexplored. Therefore, a large population-based study should be conducted to provide a detailed review of this disease.

Methods: We extracted the data of eligible patients with PCL registered in the SEER database from 1973 to 2011. All statistical analyses were performed using SPSS 19.0.

Results: A total of 2050 (61.3%) of the 3342 patients with PCL underwent surgical intervention, and 1292 (38.7%) patients received no surgical treatment. The median overall survival was 95 months, and patients receiving surgery exhibited significantly prolonged survival (adjusted HR =0.69, P <0.001). Young age, early tumor stage, and indolent lymphoma were independent predictors of improved survival. Further survival analyses demonstrated the potential benefit of surgery in patients with early tumor stage, right-sided lesions, or diffuse large B-cell PCL. Conversely, surgical intervention did not improve the survival of patients with advanced-stage, left-sided, or indolent PCL.

Conclusion: PCL is a rare tumor that can be effectively treated. Surgical intervention may play an important role in the treatment of PCL. Early tumor stage, a right-sided lesion, and diffuse large B-cell histological PCL seem to be the clinical characteristics of optimal surgical candidates.

Citing Articles

Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study.

Funaki H, Nojima N, Takikawa Y, Komori K, Hasegawa H, Sakai T Surg Case Rep. 2023; 9(1):103.

PMID: 37306807 PMC: 10260716. DOI: 10.1186/s40792-023-01688-7.


Iatrogenic Immunodeficiency Associated Lymphoproliferative Disorder in a Patient With Inflammatory Bowel Disease.

German B, Akin J, Kim S, Murphy C, Venugopal P, Lopez-Hisijos N J Med Cases. 2022; 13(10):521-524.

PMID: 36407867 PMC: 9635768. DOI: 10.14740/jmc3798.


Endoscopic features of colorectal lymphoma according to histological type.

Yachida T, Matsuda T, Sakamoto T, Nakajima T, Kakugawa Y, Maeshima A JGH Open. 2022; 6(4):257-262.

PMID: 35475204 PMC: 9021707. DOI: 10.1002/jgh3.12738.


An unusual presentation of non-IBD related colorectal primary extranodal diffuse large B cell lymphoma with a colo-colonic fistula.

Nakrani R, Yeung H, Arnon M, Selby A, Burgert-Lon C, Kamat B J Community Hosp Intern Med Perspect. 2021; 11(5):662-666.

PMID: 34567459 PMC: 8462868. DOI: 10.1080/20009666.2021.1951946.


Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.

Li P, Chai J, Chen Z, Liu Y, Wei J, Liu Y Front Oncol. 2021; 11:622648.

PMID: 33747936 PMC: 7973209. DOI: 10.3389/fonc.2021.622648.


References
1.
Rackner V, Thirlby R, RYAN Jr J . Role of surgery in multimodality therapy for gastrointestinal lymphoma. Am J Surg. 1991; 161(5):570-5. DOI: 10.1016/0002-9610(91)90902-p. View

2.
Gurney K, Cartwright R, Gilman E . Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer. 1999; 79(11-12):1929-34. PMC: 2362786. DOI: 10.1038/sj.bjc.6690307. View

3.
BUSCH E, Rodriguez-Bigas M, Mamounas E, Barcos M, Petrelli N . Primary colorectal non-Hodgkin's lymphoma. Ann Surg Oncol. 1994; 1(3):222-8. DOI: 10.1007/BF02303527. View

4.
Drolet S, MacLean A, Stewart D, Dixon E, Oddone Paolucci E, Buie W . Primary colorectal lymphoma-clinical outcomes in a population-based series. J Gastrointest Surg. 2011; 15(10):1851-7. DOI: 10.1007/s11605-011-1572-0. View

5.
Dionigi G, Annoni M, Rovera F, Boni L, Villa F, Castano P . Primary colorectal lymphomas: review of the literature. Surg Oncol. 2007; 16 Suppl 1:S169-71. DOI: 10.1016/j.suronc.2007.10.021. View